New Alternative Found for Boosting Ovarian Cancer Immune Responses

New Alternative Found for Boosting Ovarian Cancer Immune Responses
Researchers at The Wistar Institute in Philadelphia have identified an experimental drug that shows great promise in halting ovarian cancer progression. The treatment, which is currently in clinical trials for a number of cancers, is able to boost anti-tumor immunity and cause T-cells to directly target ovarian cancer cells. The study, “BET Bromodomain Inhibition Promotes Anti-tumor Immunity by

Knowledge is power when living with ovarian cancer.

Get access to the web’s leading Ovarian Cancer news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *